Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1932 1
1950 1
1957 1
1991 2
1999 1
2000 1
2003 2
2004 1
2005 2
2006 3
2007 2
2008 5
2009 1
2011 3
2012 3
2013 4
2014 4
2015 5
2016 3
2017 4
2018 5
2020 1
2021 5
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
Target regimen profiles for treatment of tuberculosis: a WHO document.
Lienhardt C, Nahid P, Rich ML, Bansbach C, Kendall EA, Churchyard G, González-Angulo L, D'Ambrosio L, Migliori GB, Raviglione M. Lienhardt C, et al. Among authors: rich ml. Eur Respir J. 2017 Jan 25;49(1):1602352. doi: 10.1183/13993003.02352-2016. Print 2017 Jan. Eur Respir J. 2017. PMID: 28122858 Free PMC article. No abstract available.
Introducing new and repurposed TB drugs: the endTB experience.
Seung KJ, Khan U, Varaine F, Ahmed S, Bastard M, Cloez S, Damtew D, Franke MF, Herboczek K, Huerga H, Islam S, Karakozian H, Khachatryan N, Kliesckova J, Khan AJ, Khan M, Khan P, Kotrikadze T, Lachenal N, Lecca L, Lenggogeni P, Maretbayeva S, Melikyan N, Mesic A, Mitnick CD, Mofolo M, Perrin C, Richard M, Tassew YM, Telnov A, Vilbrun SC, Wanjala S, Rich ML, Hewison C. Seung KJ, et al. Among authors: rich ml. Int J Tuberc Lung Dis. 2020 Oct 1;24(10):1081-1086. doi: 10.5588/ijtld.20.0141. Int J Tuberc Lung Dis. 2020. PMID: 33126943
Geographic barriers to establishing a successful hospital referral system in rural Madagascar.
Ihantamalala FA, Bonds MH, Randriamihaja M, Rakotonirina L, Herbreteau V, Révillion C, Rakotoarimanana S, Cowley G, Andriatiana TA, Mayfield A, Rich ML, Rakotonanahary RJL, Finnegan KE, Ramarson A, Razafinjato B, Ramiandrisoa B, Randrianambinina A, Cordier LF, Garchitorena A. Ihantamalala FA, et al. Among authors: rich ml. BMJ Glob Health. 2021 Dec;6(12):e007145. doi: 10.1136/bmjgh-2021-007145. BMJ Glob Health. 2021. PMID: 34880062 Free PMC article.
Culture Conversion in Patients Treated with Bedaquiline and/or Delamanid. A Prospective Multicountry Study.
Franke MF, Khan P, Hewison C, Khan U, Huerga H, Seung KJ, Rich ML, Zarli K, Samieva N, Oyewusi L, Nair P, Mudassar M, Melikyan N, Lenggogeni P, Lecca L, Kumsa A, Khan M, Islam S, Hussein K, Docteur W, Chumburidze N, Berikova E, Atshemyan H, Atwood S, Alam M, Ahmed S, Bastard M, Mitnick CD. Franke MF, et al. Among authors: rich ml. Am J Respir Crit Care Med. 2021 Jan 1;203(1):111-119. doi: 10.1164/rccm.202001-0135OC. Am J Respir Crit Care Med. 2021. PMID: 32706644 Free PMC article.
Integrating Health Systems and Science to Respond to COVID-19 in a Model District of Rural Madagascar.
Rakotonanahary RJL, Andriambolamanana H, Razafinjato B, Raza-Fanomezanjanahary EM, Ramanandraitsiory V, Ralaivavikoa F, Tsirinomen'ny Aina A, Rahajatiana L, Rakotonirina L, Haruna J, Cordier LF, Murray MB, Cowley G, Jordan D, Krasnow MA, Wright PC, Gillespie TR, Docherty M, Loyd T, Evans MV, Drake JM, Ngonghala CN, Rich ML, Popper SJ, Miller AC, Ihantamalala FA, Randrianambinina A, Ramiandrisoa B, Rakotozafy E, Rasolofomanana A, Rakotozafy G, Andriamahatana Vololoniaina MC, Andriamihaja B, Garchitorena A, Rakotonirina J, Mayfield A, Finnegan KE, Bonds MH. Rakotonanahary RJL, et al. Among authors: rich ml. Front Public Health. 2021 Jul 21;9:654299. doi: 10.3389/fpubh.2021.654299. eCollection 2021. Front Public Health. 2021. PMID: 34368043 Free PMC article.
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Maretbayeva SM, Rakisheva AS, Adenov MM, Yeraliyeva LT, Algozhin YZ, Stambekova AT, Berikova EA, Yedilbayev A, Rich ML, Seung KJ, Issayeva AM. Maretbayeva SM, et al. Among authors: rich ml. Int J Infect Dis. 2021 Dec;113 Suppl 1:S91-S95. doi: 10.1016/j.ijid.2021.03.075. Epub 2021 Apr 3. Int J Infect Dis. 2021. PMID: 33823277 Free article.
Programmes and principles in treatment of multidrug-resistant tuberculosis.
Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, Furin JJ, Becerra MC, Barry DJ, Kim JY, Bayona J, Farmer P, Smith Fawzi MC, Seung KJ. Mukherjee JS, et al. Among authors: rich ml. Lancet. 2004 Feb 7;363(9407):474-81. doi: 10.1016/S0140-6736(04)15496-2. Lancet. 2004. PMID: 14962530 Review.
Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial.
Guglielmetti L, Ardizzoni E, Atger M, Baudin E, Berikova E, Bonnet M, Chang E, Cloez S, Coit JM, Cox V, de Jong BC, Delifer C, Do JM, Tozzi DDS, Ducher V, Ferlazzo G, Gouillou M, Khan A, Khan U, Lachenal N, LaHood AN, Lecca L, Mazmanian M, McIlleron H, Moschioni M, O'Brien K, Okunbor O, Oyewusi L, Panda S, Patil SB, Phillips PPJ, Pichon L, Rupasinghe P, Rich ML, Saluhuddin N, Seung KJ, Tamirat M, Trippa L, Cellamare M, Velásquez GE, Wasserman S, Zimetbaum PJ, Varaine F, Mitnick CD. Guglielmetti L, et al. Among authors: rich ml. Trials. 2021 Sep 25;22(1):651. doi: 10.1186/s13063-021-05491-3. Trials. 2021. PMID: 34563240 Free PMC article.
61 results